Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: shortness of breath major surgical or invasive procedure: cardiac catheterization. avr (#25 ce pericardial), cabg x 4 (lima>lad, svg>diag>om, svg>pda) on history of present illness: 67 yom progressively doe on exertion for one week with associated chest pressure. the patient presented to podiatry, and was found to be in hf. referred to osh ed for evaluation which found hf and nstemi. transferred to for further cardiac evaluation. past medical history: dm ii pad htn dyslipidemia smoking history spinal stenosis djd peripheral neuropathy osa, not on cpap social history: quit smoking 25 years ago. prior 3ppdx 15-20 years. etoh /wk. no other drugs. family history: cad in father in mid 60s. no dm. no scd. physical exam: exam: 90% on nonrebreather jvp 10cm crackles 1/3 up bilaterally + 1 le edema discharge vitals 98.6 sr 71 105/53 22rr, ra sat 90-92% wt 84kg neuro a/ox3 non focal mae rleg 5/5 l leg pulm fine crackles bilat bases cardiac rrr no murmur/rub/gallop gi abd soft, nt, nd, +bs bm ext warm pulses palpable +1 edema incision sternal healing no erythema/drainage sternum stable, steris left leg - evh steris healin no erythema/drainage pertinent results: 05:55am blood wbc-11.3* rbc-3.36* hgb-9.9* hct-29.7* mcv-89 mch-29.5 mchc-33.3 rdw-14.0 plt ct-391 06:15pm blood wbc-10.2 rbc-3.49* hgb-10.8* hct-31.9* mcv-91 mch-30.8 mchc-33.8 rdw-13.5 plt ct-265 07:00am blood neuts-75.7* lymphs-15.4* monos-4.7 eos-3.6 baso-0.5 06:15am blood pt-20.8* inr(pt)-2.0* 05:55am blood plt ct-391 06:15pm blood pt-13.6* ptt-26.2 inr(pt)-1.2* 06:15pm blood plt ct-265 05:55am blood pt-18.6* ptt-29.9 inr(pt)-1.8* 10:15am blood pt-19.6* ptt-29.1 inr(pt)-1.9* 12:00pm blood plt ct-431 12:00pm blood pt-17.6* ptt-27.8 inr(pt)-1.6* 03:55am blood pt-15.8* ptt-26.6 inr(pt)-1.4* 06:15am blood creat-1.6* k-4.5 05:55am blood glucose-47* urean-28* creat-1.4* na-140 k-4.5 cl-104 hco3-29 angap-12 06:15pm blood glucose-131* urean-35* creat-1.3* na-140 k-4.0 cl-108 hco3-21* angap-15 12:00pm blood calcium-9.1 phos-3.8 mg-2.5 07:47am blood caltibc-238* vitb12-542 folate-greater th ferritn-421* trf-183* 06:15pm blood %hba1c-6.7* -done -done 07:47am blood triglyc-120 hdl-49 chol/hd-3.8 ldlcalc-112 ekg sinus rhythm right bundle branch block consider septal myocardial infarction, age indeterminate st-t wave abnormalities - cannot exclude in part ischemia - clinical correlation is suggested since previous tracing of , no significant change read by: , w. intervals axes rate pr qrs qt/qtc p qrs t 85 178 140 37 110 cxr chest (pa & lat) 9:13 am chest (pa & lat) reason: r/o inf, eff medical condition: 67 year old man with nstemi, chf, fever. reason for this examination: r/o inf, eff indication: chf, fever. rule out infiltrate or effusion. comparison: multiple x-rays from to . pa and lateral radiographs of the chest: there has been slight improvement to the bilateral perihilar airspace opacities. underlying cystic lucencies are becoming more prominent, which may be due to pre-existing emphysema or pneumatoceles from recent barotrauma. loculated left pleural effusion is unchanged. the patient is status post median sternotomy, cabg, and avr. impression: slight improvement in bilateral interstitial opacities which may represent asymmetrical edema, though with a new history of fever, infection is also a possibility. underlying cystic lucencies may represent pre-existing emphysema or pneumatoceles from recent barotrauma. the study and the report were reviewed by the staff radiologist. dr. dr. approved: mon 1:13 pm tee patient/test information: indication: coronary artery disease. h/o cardiac surgery. left ventricular function. valvular heart disease. height: (in) 69 weight (lb): 198 bsa (m2): 2.06 m2 bp (mm hg): 146/59 hr (bpm): 86 status: inpatient date/time: at 13:18 test: portable tte (complete) doppler: full doppler and color doppler contrast: none tape number: 2007w018-1:03 test location: west micu technical quality: adequate referring doctor: dr. measurements: left atrium - long axis dimension: *5.5 cm (nl <= 4.0 cm) left atrium - four chamber length: *5.8 cm (nl <= 5.2 cm) right atrium - four chamber length: *6.0 cm (nl <= 5.0 cm) left ventricle - septal wall thickness: *1.3 cm (nl 0.6 - 1.1 cm) left ventricle - inferolateral thickness: *1.3 cm (nl 0.6 - 1.1 cm) left ventricle - diastolic dimension: *5.8 cm (nl <= 5.6 cm) left ventricle - ejection fraction: 20% to 25% (nl >=55%) aorta - valve level: 2.7 cm (nl <= 3.6 cm) aortic valve - peak velocity: 1.9 m/sec (nl <= 2.0 m/sec) mitral valve - e wave: 1.1 m/sec mitral valve - a wave: 0.8 m/sec mitral valve - e/a ratio: 1.38 mitral valve - e wave deceleration time: 213 msec interpretation: findings: this study was compared to the prior study of . left atrium: moderate la enlargement. left ventricle: mild symmetric lvh. mildly dilated lv cavity. severely depressed lvef. no resting lvot gradient. no vsd. right ventricle: moderate global rv free wall hypokinesis. aorta: normal aortic diameter at the sinus level. aortic valve: bioprosthetic aortic valve prosthesis (avr). avr well seated, normal leaflet/disc motion and transvalvular gradients. no ar. mitral valve: mildly thickened mitral valve leaflets. mild to moderate (+) mr. eccentric mr jet. tricuspid valve: mildly thickened tricuspid valve leaflets. pericardium: no pericardial effusion. conclusions: the left atrium is moderately dilated. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity is mildly dilated. overall left ventricular systolic function is severely depressed with global hypokinesis. there is no ventricular septal defect. there is moderate global right ventricular free wall hypokinesis. a bioprosthetic aortic valve prosthesis is present (not well seen, but by op note, a magna tissue valve was placed on ). the aortic prosthesis appears well seated with normal transvalvular gradients. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. mild to moderate (+) mitral regurgitation is seen. the mitral regurgitation jet is eccentric. the tricuspid valve leaflets are mildly thickened. there is no pericardial effusion. compared to the prior study dated , the lvef and rvef are now lower. by report (not well seen) an aortic valve bioprosthesis is now present. the degree of mitral regurgitation is similar. electronically signed by , md on 15:06. physician: , brief hospital course: cardiac catheterization here showed severe 3 vd. cardiac surgery was consulted and he underwent preoperative workup and awaited diuresis and plavix washout. he was also placed on levofloxacin for presumes pneumonia. on he was taken to the operating room where he underwent a cabgx4 and avr with tissue valve. he was transferred to the icu in critical but stable condition on milrinone and levophed. he was extubated and weaned from his vasoactive srips on pod #1. he was started on amiodarone on pod #2 for intermittent atrial fibrillation. he became bradycardic, and was seen by electrophysiology who recomended contining po amio and using lopressor instead. he should also follow up with dr. in 6 weeks for an icd evaluation given his ventricular ectopy. he was also started on coumadin for his a fib. he was transferred to the floor on pod #5. on pod #7 he was transferred back to the icu for hypotension after his ace inhibitor and beta blocker were increased aggreseively. his doses were decreased, his blood pressure improved and he was transferred back to the floor on pod #8. pulmonary was consulted and will follow up with him as an outpatient. he continued to progressed and was ready for discharge to rehab on pod 12 with of hearts monitor. medications on admission: labetalol 200 mg qd norvasc 10 mg qd actos 30 mg qd glipizide 10 mg qd discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 2. atorvastatin 20 mg tablet sig: one (1) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*0* 3. glipizide 10 mg tab,sust rel osmotic push 24hr sig: one (1) tab,sust rel osmotic push 24hr po daily (daily). disp:*30 tab,sust rel osmotic push 24hr(s)* refills:*0* 4. pioglitazone 15 mg tablet sig: two (2) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 5. carvedilol 12.5 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*120 tablet(s)* refills:*0* 6. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 7. lisinopril 5 mg tablet sig: one (1) tablet po daily (daily). 8. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. 9. amiodarone 400 mg tablet sig: one (1) tablet po twice a day: 400 x 1 week, then 200 mg daily for three weeks. 10. furosemide 40 mg tablet sig: one (1) tablet po twice a day. 11. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 12. warfarin 2 mg tablet sig: one (1) tablet po once a day: please take and - check inr . 13. lorazepam 0.5 mg tablet sig: one (1) tablet po hs (at bedtime) as needed. discharge disposition: extended care facility: rehab & nursing center - discharge diagnosis: as cad dm htn djd sleep apnea peripheral neuropathy discharge condition: good discharge instructions: of hearts monitor - twice a day readings to holter lab at shower, no baths or swimming monitor wounds for infection - redness, drainage, or increased pain report any fever greater than 101 report any weight gain of greater than 2 pounds in 24 hours or 5 pounds in a week no creams, lotions, powders, or ointments to incisions no driving for approximately one month no lifting more than 10 pounds for 10 weeks please call with any questions or concerns followup instructions: with dr. after discharge from rehab with dr. in 4 weeks dr. after discharge from rehab dr. (ep) please call to schedule ( please call to schedule all appointments of hearts monitor - holter lab ( - dr to follow provider: function lab phone: date/time: 2:30 provider: , intepretation billing date/time: 2:30 provider: . /dr. phone: date/time: 3:30 pt/inr as needed first draw goal inr 2.0-2.5 for atrial fibrillation sleep study to evaluate for sleep apnea after recovery from surgery procedure: (aorto)coronary bypass of three coronary arteries extracorporeal circulation auxiliary to open heart surgery combined right and left heart cardiac catheterization coronary arteriography using two catheters diagnostic ultrasound of heart (aorto)coronary bypass of one coronary artery open and other replacement of aortic valve with tissue graft transfusion of packed cells diagnoses: pneumonia, organism unspecified obstructive sleep apnea (adult)(pediatric) subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified atrial fibrillation chronic kidney disease, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction rheumatic heart failure (congestive) long-term (current) use of anticoagulants mitral valve insufficiency and aortic valve stenosis family history of ischemic heart disease unspecified hereditary and idiopathic peripheral neuropathy 

Answer: The patient is high likely exposed to